NICE — Íàöèîíàëüíûé èíñòèòóò çäîðîâüÿ è êëèíè÷åñêîãî ñîâåðøåíñòâîâàíèÿ (êà÷åñòâà ìåäèöèíñêîé ïîìîùè) Âåëèêîáðèòàíèè (National Institute for Health and Clinical Excellence)
NK — åñòåñòâåííûå êëåòêè-êèëëåðû (natural killer)
NMDA — N-ìåòèë-D-àñïàðòàò (N-methyl-D-aspartate)
NMDA — N-ìåòèë-D-àñïàðòàòíûå ðåöåïòîðû
NNT — ÷èñëî áîëüíûõ, êîòîðûõ íåîáõîäèìî ïðîëå÷èòü, ÷òîáû äîñòè÷ü êàêîãî-òî óêàçàííîãî ýôôåêòà (Number Need to Treatment)
OR — îòíîøåíèå øàíñîâ (odds ratio)
paCO2 — ïàðöèàëüíîå äàâëåíèå óãëåêèñëîãî ãàçà â àðòåðèàëüíîé êðîâè
PALS — êóðñû ðàñøèðåííûõ ðåàíèìàöèîííûõ ìåðîïðèÿòèé â ïåäèàòðèè (Pediatric Advanced Life Support)
PANDAS — àóòîèììóííîå íåéðîïñèõèàòðè÷åñêîå ðàññòðîéñòâî â äåòñêîì âîçðàñòå, àññîöèèðîâàííîå ñî ñòðåïòîêîêêîâîé èíôåêöèåé (Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection)
 õîäå ïîäãîòîâêè ñòàòåé ïî äåòñêîé íåôðîëîãèè â ïåäèàòðèè äëÿ ïîëüçîâàòåëåé ñàéòà ÌåäÓíèâåð èñïîëüçîâàíû òðóäû ñëåäóþùèõ àâòîðîâ:
Bates G, Ho J, Sims-Lucas S, et al: Embryonic development of the kidney. In Avner ED, Harmon WE, Niaudet P, editors: Pediatric nephrology, ed 7, Heidelberg, Germany, 2016, Springer-Verlag, pp 3–36.
Tufro A, Gulati A, et al: Development of glomerular circulation and function. In Avner ED, Harmon WE, Niaudet P, editors: Pediatric nephrology, ed 7, Heidelberg, Germany, 2016, Springer-Verlag, pp 37–59.
Arant BS Jr: Postnatal development of renal function during the first year of life, Pediatr Nephrol 1:308–313, 1987.
Filler G, Yasin A, Medeiros M: Methods of assessing renal function, Pediatr Nephrol 29:183–192, 2014.
Gao A, Cachat F, Faouzi M, et al: Comparison of the glomerular filtration rate in children by the new revised Schwartz formula and a new generalized formula, Kidney Int 83:524–530, 2013.
Tufro A, Gulati A, et al: Development of glomerular circulation and function. In Avner ED, Harmon WE, Niaudet P, editors: Pediatric nephrology, ed Heidelberg, Germany, 2016, Springer-Verlag, pp 37–59.
Schwartz GJ, Mu?oz A, Schneider MF, et al: New equations to estimate GFR in children with CKD, J Am Soc Nephrol 20:629–637, 2009.
Fogo A, et al: Pediatric renal pathology. In Avner ED, Harmon WE, Niaudet P, editors: Pediatric nephrology, ed 7, Heidelberg, Germany, 2016, Springer-Verlag, pp 705–749.
Nagata M, et al: Immune-mediated glomerular injury in children. In Avner ED, Harmon WE, Niaudet P, editors: Pediatric nephrology, ed 7, Heidelberg, Germany, 2016, Springer-Verlag, pp 883–926.
Aycock RD, Kass DA: Abnormalurinecolor, SouthMedJ 105(1):43–47, 2012.
Bergstein J, Leiser J, Andreoli S: The clinical significance of asymptomatic gross and microscopic hematuria in children, Arch Pediatr Adolesc Med 159:353–355, 2005.
Gale DP: How benign is hematuria? Using genetics to predict prognosis, PediatrNephrol 28:1183–1193, 2013.
Higashihara E, Nishiyama T, Horie S, et al: Hematuria: definition and screening test methods, Int J Urol 15:281–284, 2008.
Kiragu D, Cifu AS: Evaluation of patients with asymptomatic microhematuria, JAMA 314(17):1865–1866, 2015.
Meyers KE: Evaluation of hematuria in children, Urol Clin North Am 3:559–573, 2004.
Omoloja AA, Patel H, Ey E, et al: Common renal problems in pediatric medicine, Curr Probl Pediatr Adolesc Health Care 37:145–200, 2007.
Pan CG: Evaluation of gross hematuria, Pediatr Clin North Am 53:401–412, 2007.
Spivacow FR, Del Valle EE, Rey PG: Metabolic risk factors in children with asymptomatic hematuria, Pediatr Nephrol 31(7):1101–1106, 2016.
Vivante A, Afek A, Frenkel-Nir Y, et al: Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease, JAMA 306(7):729–736, 2011.
Wenderfer SE, Gaut JP: Glomerular diseases in children, Adv Chronic Kidney Dis 24(6):364–371, 2017.
Boyd JK, Cheung CK, Molyneux K, et al: An update on the pathogenesis and treatment of IgA nephropathy, Kidney Int 81:833–843, 2012.
Fellstrom BC, Barratt J, Cook H, et al: Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomized, placebo-controlled, phase 2b trial, Lancet 389(10084):2117–2127, 2017.
Kawasaki Y, Maeda R, Kanno S, et al: Comparison of long-term follow-up outcomes between multiple-drugs combination therapy and tonsillectomy pulse therapy for pediatric IgA nephropathy, Clin Exp Nephrol 22(4):917–923, 2018.
Lv J, Zhang H, Wong MG, et al: Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial, JAMA 318(5):432–442, 2017.
Manno C, Torres DD, Rossini M, et al: Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy, Nephrol Dial Transplant 24(12):3694–3701, 2009.
Sanders JT, Wyatt RJ: IgA nephropathy and Henoch-Sch?nlein purpura nephritis, Curr Opin Pediatr 20:163–170, 2008.
Tang SC, Tang AW, Wong SS, et al: Long-term study of mycophenolate mofetil treatment in IgA nephropathy, Kidney Int 77(6):543–549, 2010.
Wyatt RJ, Julian BA: IgA nephropathy, N Engl J Med 368:2402–2414, 2013.
Gross O, Kasthan CE, Rheault MN, et al: Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 international workshop on Alport syndrome, Nephrol Dial Transplant 32(6):916–924, 2017.
Heidet L, Gubler MC: The renal lesions of Alport syndrome, J Am Soc Nephrol 20:1210–1215, 2009.
Kashtan CE: Familial hematuria due to type IV collagen mutations: Alport syndrome and thin basement membrane nephropathy, Curr Opin Pediatr 16:177–181, 2004.
Kashtan CE, Gubler MC, et al: Inherited glomerular diseases. In Avner ED, Harmon WE, Niaudet P, editors: Pediatric nephrology, ed 6, Heidelberg, Germany, 2009, Springer-Verlag, pp 621–642.
Plaisier E, Bribouval O, Alamowitch S, et al: COL4A1 mutations and hereditary angi-opathy, nephrology, aneurysms, and muscle cramps, N Engl J Med 357(6):2687–2695, 2007.
Savige J, Gregory M, Gross O, et al: Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy, J Am Soc Nephrol 24:364–375, 2013.
Savige J, Storey H, Il Cheong H, et al: X-linked and autosomal recessive Alport syndrome: pathogenic variant features and further genotype-phenotype correlations, PLoSONE 11(9):e0161802, 2016.
Zhang Y, Ding J: Renal, auricular, and ocular outcomes of Alport syndrome and their current management, Pediatr Nephrol 33(8):1309–1316, 2018.
Kashtan CE: Familial hematuria due to type IV collagen mutations: Alport syndrome and thin basement membrane nephropathy, Curr Opin Pediatr 16(2):177–181, 2004.
Tonna S, Wang YY, MacGregor D, et al: The risks of thin basement membrane nephropathy, Semin Nephrol 25:171–175, 2005.
Balasubramanian R, Marks SD: Post-infectious glomerulonephritis, Paediatr Int ChildHealth 37(4):240–247, 2017.
Eison TM, Ault BH, Jones DP, et al: Post-streptoccocal acute glomerulonephritis in children: clinical features and pathogenesis, Pediatr Nephrol 26:165–180, 2011.
Hoy WE, White AV, Dowling A, et al: Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life, Kidney Int 81:1026–1032, 2012.
Martin J, Kaul A, Schacht R: Acute poststreptococcal glomerulonephritis: a manifestation of immune reconstitution inflammatory syndrome, Pediatrics 130:e710–e713, 2012.
Pais PJ, Kump T, Greenbaum LA: Delay in diagnosis in poststreptococcal glomeru-lonephritis, J Pediatr 153:560–564, 2008.
Rodriquez-Iturbe B, Mezzano S, et al: Acute postinfectious glomerulonephritis. In Avner ED, Harmon WE, Niaudet P, editors: Pediatric nephrology, ed 6, Heidelburg, Germany, 2009, Springer-Verlag, pp 743–756.
Avalon R, Beck LH Jr: Membranous nephropathy: not just a disease for adults, PediatrNephrol 30(1):31–39, 2015.
Debiec H, Lefeu F, Kemper MJ, et al: Early childhood membranous nephropathy due to cationic bovine serum albumin, N Engl J Med 364(22):2101–2110, 2011.
Fervenza FC, Cosio FG, Erickson FB, et al: Rituximab treatment in idiopathic membranous nephropathy, Kidney Int 73:117–125, 2008.
Murtas C, Bruschi M, Candiano G, et al: Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy, Clin J Am Soc Nephrol 7:1394–1400, 2012.
Pereira M, Muscal E, Eldin K, et al: Clinical presentation and outcomes of childhood-onset membranous lupus nephritis, Pediatr Nephrol 32(12):2283–2291, 2017.
Ronco P, Debiec H: Pathophysiological advances in membranous nephropathy: time for a shift in patient’s care, Lancet 385:1983–1992, 2015.
Ruggebebti P, Remuzzi G: Idiopathic membranous nephropathy: back to the future?, Lancet 381: 706–708, 2013.
Waldman M, Austin HA 3rd: Treatment of idiopathic membranous nephropathy, J Am Soc Nephrol 23:1617–1630, 2012.
Kawasaki Y, Kanno S, Ono A, et al: Differences in clinical findings, pathology, and outcomes between C3 glomerulonephritis and membranoproliferative glomeru-lonephritis, Pediatr Nephrol 31(7):1091–1099, 2016.
Sethi S, Fervenza FC: Membranoproliferative glomerulonephritis—a new look at an old entity, N Engl J Med 366(12):1119–1131, 2012.
Sethi S, Nester CM, Smith RJ: Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion, Kidney Int 81(5):434–441, 2012.
Jindal KK: Management of idiopathic crescentic and diffuse proliferative glomerulo-nephritis: evidence based recommendations, Kidney Int 70:S33–S40, 1999.
Rianthavorn P, Chacranon M: Long-term renal outcome in pediatric glomerulonephritis associated with crescent formation, Clin Exp Nephrol 22(3):661–667, 2018.
Singh SK, Jeansson M, Quaggin SE: New insights into the pathogenesis of cellular crescents, Curr Opin Nephrol Hypertens 20:258–262, 2011.
Walsh M, Catapano F, Szpirt W, et al: Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis, Am J KidneyDis 57:566–574, 2011.
Barsoum RS, William EA, Khalil SS: Hepatitis C and kidney disease: a narrative review, J Adv Res 8(2):113–130, 2017.
Fabrizi F, Donato FM, Messa P: Association between Hepatitis B virus and chronic kidney disease: a systematic review and meta-analysis, Ann Hepatol 16(1):21–47, 2017.
Kupin WL: Viral-associated GN: Hepatitis B and other viral infections, Clin J AmSoc Nephrol 12(9):1529–1533, 2017.
Kupin WL: Viral-associated GN: Hepatitis C and HIV, Clin J Am Soc Nephrol 12(8):1337–1342, 2017.
Nobakht E, Cohen SD, Rosenberg AZ, Kimmel PL: HIV-associated immune complex kidney disease, Nat Rev Nephrol 12(5):291–300, 2016.
Purswani MU, Chernoff MC, Mitchell CD, et?al: Chronic kidney disease associated with perinatal HIV infection in children and adolescents, Pediatr Nephrol 27:981–989, 2012.
Rosenberg AZ, Naicker S, Winkler CA, Kopp JB: HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment, Nat Rev Nephrol 11(3):150–160, 2015.
Almaani S, Meara A, Rovin BH: Update on Lupus Nephritis, Clin J Am Soc Nephrol 12(5):825–835, 2017.
Mahmoud I, Jellouli M, Boukhris I, et?al: Efficacy and safety of rituximab in the management of pediatric systemic lupus erythematosus: a systematic review, J Pediatr 187:213–219, e2, 2017.
Tanaka H, Joh K, Imaizumi T: Treatment of pediatric-onset lupus nephritis: a proposal of optimal therapy, Clin Exp Nephrol 21(5):755–763, 2017.
Tian SY, Silverman ED, Pullenayegum E, et?al: Comparative effectiveness of mycophe-nolate mofetil for the treatment of childhood-onset proliferative lupus nephritis, Arthritis Care Res (Hoboken) 69(12):1887–1894, 2017.
Wenderfer SE, Ruth NM, Brunner HI: Advances in the care of children with lupus nephritis, Pediatr Res 81(3):406–414, 2017.
Chen JY, Mao JH: Henoch-Sch?nlein purpura nephritis in children: incidence, pathogenesis and management, World J Pediatr 11(1):29–34, 2015.
Lu S, Liu D, Xiao J, et?al: Comparison between adults and children with Henoch-Sch?nlein purpura nephritis, Pediatr Nephrol 30(5):791–796, 2015.
Lu Z, Song J, Mao J, et?al: Evaluation of mycophenolate mofetil and low-dose steroid combined therapy in moderately severe Henoch-Sch?nlein purpura nephritis, MedSci Monit 23:2333–2339, 2017.
Alchi B, Griffiths M, Sivalingam M, et?al: Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort, NephrolDial Transplant 30(5):814–821, 2015.
Greco A, Rizzo MI, De Virgilio A, et?al: Goodpasture’s syndrome: a clinical update, Autoimmun Rev 14(3):246–253, 2015.
Henderson SR, Salama AD: Diagnostic and management challenges in Goodpas-ture’s (anti-glomerular basement membrane) disease, Nephrol Dial Transplant 33(2):196–202, 201
L’Imperio V, Ajello E, Pieruzzi F, et?al: Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis, J Nephrol 30(4):503–509, 2017.
Touzot M, Poisson J, Faguer S: Rituximab in anti-GBM disease: a retrospective study of 8 patients, J Autoimmun 60:74–79, 2015.
Angioi A, Fervenza FC, Sethi S, et?al: Diagnosis of complement alternative pathway disorders, Kidney Int 89(2):278–288, 2016.
Ardissino G, Tel F, Possenti I, et?al: Early volume expansion and outcomes of hemolytic uremic syndrome, Pediatrics 137(1):e20152153, 2016.
Carter S, Hewitt I, Kausman J: Long-term remission with eculizumab in atypical haemolytic uraemic syndrome, Nephrology (Carlton) (Suppl 1):7–10, 2017.
Cullinan N, Gorman KM, Riordan M, et?al: Case report: benefits and challenges of long-term eculizumab in atypical hemolytic uremic syndrome, Pediatrics 135(6):e1507–e1509, 2015.
de Buys Roessingh AS, de Lagausie P, Loirat VB, Algrain Y: Gastrointestinal complica-tions of post-diarrheal hemolytic uremic syndrome, Eur J Pediatr Surg 17:328–334, 2007.
Grango S, Bekri S, Artaud-Macari E, et al: Adult-onset renal thrombotic microan-giopathy and pulmonary arterial hypertension in cobalamin C deficiency, Lancet 386:1011–1012, 2015.
Jokiranta TS: HUS and atypical HUS, Blood 129(21):2847–2856, 2017.
Loirat C, Fakhouri F, Ariceta G, et?al: An international consensus approach to the management of atypical hemolytic uremic syndrome in children, Pediatr Nephrol 31(1):15–39, 2016.
Masias C, Vasu S, Cataland SR: None of the above: thrombotic microangiopathy beyond TTP and HUS, Blood 129(21):2857–2863, 2017.
McNamara LA, Topaz N, Wang X, et?al: High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine, MMWR Morb Mortal Wkly Rep 66(27):734–736, 2017.
Mody RK, Gu W, Griffin PM, et?al: Postdiarrheal hemolytic uremic syndrome in United States children: clinical spectrum and predictors of in-hospital death, J Pediatr 166:1022–1029, 2015.
Morton V, Cheng JM, Sharma D, Kearney A: An outbreak of Shiga toxin–producing Escherichia coli O121 infections associated with flour, Canada, 2016-2017, Can Commun Dis Rep 43(7-8):154–155, 2017.
Awdishu L, Mehta RL: The 6 Rs of drug induced nephrotoxicity, BMC Nephrol 18(1):124, 2017.
Fohling M, Seeliger E, Patzak A, et?al: Understanding and preventing contrast-induced acute kidney injury, Nat Rev Nephrol 13(3):169–180, 2017.
Goldstein SL, Kirkendall E, Nguyen H, et al: Electronic health record identification of nephrotoxin exposure and associated acute kidney injury, Pediatrics 132(3): e756–e767, 2013.
Goldstein SL, Mottes T, Simpson K, et?al: A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury, Kidney Int 90(1): 212–221, 2016.
Wolf MTF: Nephronophthisis and related syndromes, Curr Opin Pediatr 27:201–211, 2015.
Jung DC, Kim SH, Jung SI, et al: Renal papillary necrosis: review and comparison of findings at multi-detector row CT and intravenous urography, Radiographics 26(6):1827–1836, 2006.
Sutariya HC, Pandya VK: Renal papillary necrosis: role of radiology, J Clin DiagnRes 10(1):TD10–TD12, 2016.
Ciccia E, Devarajan P: Pediatric acute kidney injury: prevalence, impact and management challenges, Int J Nephrol Renovasc Dis 10:77–84, 2017.
Devarajan P: Acute kidney injury: still misunderstood and misdiagnosed, Nat RevNephrol 13(3):137–138, 2017.
Kaddouhah A, Basu RK, Bagshaw SM, et al: Epidemiology of acute kidney injury in critically ill children and young adults, N Engl J Med 376(1):11–20, 2017.
McCaffrey J, Dhakal AK, Milford DV, et?al: Recent developments in the detection and management of acute kidney injury, Arch Dis Child 102(1):91–96, 2017.
Ananthan K, Onida S, Davies AH: Nutcracker syndrome: an update on current diagnostic criteria and management guidelines, Eur J Vasc Endovasc Surg 53(6):886–894, 2017.
Flum AS, Hamoui N, Said MA, et al: Update on the diagnosis and management of renal angiomyolipoma, J Urol 195(4 Pt 1):834–846, 2016.
Samuels JA: Treatment of renal angiomyolipoma and other hamartomas in patients with tuberous sclerosis complex, Clin J Am Soc Nephrol 12(7):1196–1202, 2017.
Resontoc LP, Yap HK: Renal vascular thrombosis in the newborn, Pediatr Nephrol 31(6):907–915, 2016.
Airy M, Eknoyan G: The kidney in sickle hemoglobinopathies, Clin Nephrol 87(2):55–68, 2017.
Ataga MI, Derebail VK, Archer DR: The glomerulopathy of sickle cell disease, Am J Hematol 89(9):907–914, 2014.
Mammen C, Bissonnette ML, Matsell DG: Acute kidney injury in children with sickle cell disease-compounding a chronic problem, Pediatr Nephrol 32(8):1287–1291, 2017.
Nath KA, Hebbel RP: Sickle cell disease: renal manifestations and mechanisms, NatRev Nephrol 11(3):161–171, 2015.
Quinn CT, Saraf SL, Gordeuk VR, et al: Losartan for the nephropathy of sickle cell anemia: a phase-2, multicenter trial, Am J Hematol 92(9):E520–E528, 2017.
Coe FL, Worcester EM, Evan AP: Idiopathic hypercalciuria and formation of calcium renal stones, Nat Rev Nephrol 12(9):519–533, 2016.
Evan AP, Worcester EM, Coe FL, et?al: Mechanisms of human kidney stone formation, Urolithiasis 43(Suppl 1):19–32, 2015.
Tasian GE, Copelovitch L: Evaluation and medical management of kidney stones in children, J Urol 192(5):1329–1336, 2014.
Tasic V, Gucev Z: Nephrolithiasis and nephrocalcinosis in children: metabolic and genetic factors, Pediatr Endocrinol Rev 13(1):468–476, 2015.
Ticinesi A, Nouvenne A, Maalouf NM, et?al: Salt and nephrolithiasis, Nephrol DialTransplant 31(1):39–45, 2016.
Bergman C: ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopies, Pediatr Nephrol 30:15–30, 2015.
Cramer MT, Guay-Woodford LM: Cystic kidney disease: a primer, Adv Chronic KidneyDis 22(4):297–305, 2015.
Dell KM, Avner ED: Autosomal recessive polycystic kidney disease. In Gene Clinics: Clinical Genetic Information Resource (database online).
Guay-Woodford LM, Bissler JJ, Braun MC, et?al: Consensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: report of an international conference, J Pediatr 165:611–617, 2014.
Hartung EA, Guay-Woodford LM: Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects, Pediatrics 134:e833–e845, 2014.
Sweeney WE Jr, Avner ED: Emerging therapies for childhood polycystic kidney disease, Front Pediatr. 5:77, 2017.
Telega G, Cronin D, Avner ED: New approaches to the ARPKD patient with dual kidney-liver complications, Pediatr Transplant 17:328–335, 2013.
Wehrman A, Kriegermeier A, Wen J: Diagnosis and management of hepatobiliary complications in autosomal recessive polycystic kidney disease, Front Pediatr. 5:124, 2017.
Beck L, Bombeck AS, Choi MJ, et al: KDOQI vs commentary on the 2012 KDIGO clinical practice guidelines for glomerulonephritis, Am J Kidney Dis 63:403–441, 2013.
Cadnapaphornchai MA: Clinical trials in pediatric autosomal dominant polycystic kidney disease, Front Pediatr. 5:53, 2017.
Mao Z, Chong J, Ong AC: Autosomal dominant polycystic kidney disease: recent advances in clinical management, F1000Res 5:2029, 2016.
Ong AC, Devuyst O, Knebelmann B, et al: Autosomal dominant polycystic kidney disease: the changing face of clinical management, Lancet 385(9981):1993–2002, 2015.
Ong ACM: Making sense of polycystic kidney disease, Lancet 389:1780–1782, 2017.
Reddy BV, Chapman AB: The spectrum of autosomal dominant polycystic kidney disease in children and adolescents, Pediatr Nephrol 32(1):31–42, 2017.
Torres VE, Chapman AB, Devuyst O, et al: Tolvaptan in patients with autosomal dominant polycystic kidney disease, N Engl J Med 267(25):2407–2418, 2012.
Chouhan JD, Winer AG, Johnson C, et al: Contemporary evaluation and management of renal trauma, Can J Urol 23(2):8191–8197, 2016.
Dane B, Baxter AB, Bernstein MP: Imaging genitourinary trauma, Radiol Clin North Am 55(2):321–335, 2017.
LeeVan E, Zmora O, Cazzulino F, et al: Management of pediatric blunt renal trauma: a systematic review, J Trauma Acute Care Surg 80(3):519–528, 2016.
Lloyd GL, Slade S, McWilliams KL, et al: Renal trauma from recreational accidents manifests different injury patterns than urban renal trauma, J Urol 188:163–168, 2012.
Au JK, Graziano C, Elizondo RA, et?al: Urologic outcomes of children with hemorrhagic cystitis after bone marrow transplant at a single institution, Urology 101:126–132, 2017.
Johnston D, Schurtz E, Tourville E, et al: Risk factors associated with severity and outcomes in pediatric patients with hemorrhagic cystitis, J Urol 195(4 Pt 2): 1312–1317, 2016.
Pitto CM, Garc?a-Perdomo HA: Interventions to treat hemorrhagic cystitis: a systematic review and meta-analysis, Support Care Cancer 25(7):2043–2046, 2017.
Riachy E, Krauel L, Rich BS, et?al: Risk factors and predictors of severity score and complications of pediatric hemorrhagic cystitis, J Urol 191(1):186–192, 2014.
Shephard RJ: Exercise proteinuria and hematuria: current knowledge and future directions, J Sports Med Phys Fitness 56(9):1060–1076, 2016.
Abitbol C, Zilleruelo G, Freundlich M, et?al. Quantitation of proteinuria with urinary protein/creatinine ratios and random testing with dipsticks in nephrotic syndrome, J Pediatr 116:243–247, 1990.
Brandt JR, Jacobs A, Raissy HH, et?al. Orthostatic proteinuria and the spectrum of diurnal variability of urinary protein excretion in healthy children, Pediatr Nephrol 25(6):1131–1137, 2010.
Browne OT, Bhandari S. Interpreting and investigating proteinuria, BMJ 343:d5146, 2011.
Hogg R, Portman RJ, Milliner D, et al. Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation Conference of Proteinuria, Albuminuria, Risk, Assessment, Detection, and Elimination, Pediatrics 105:1242–1249, 2000.
Rademacher E, Sinaiko A. Albuminuria in children, Curr Opin Nephrol Hypertens 18:246–251, 2009.
Tryggvason K, Patrakka J, Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria, N Engl J Med;354:1387–1401, 2006.
Ariceta G. Clinical practice: proteinuria, Eur J Pediatr 17:15–20, 2011.
Hogg RJ. Adolescents with proteinuria and/or the nephritic syndrome, Adolesc Med 16:163–172, 2005.
Ariceta G. Clinical practice: proteinuria, Eur J Pediatr 17:15–20, 2011.
Brandt J, Jacobs A, Hengameh H, et al. Orthostatic proteinuria and the spectrum of diurnal variability of urinary protein excretion in healthy children, Pediatr Nephrol 25:1131–1137, 2010.
Milani G, Mazzoni M, Burdick L, et al. Postural proteinuria associated with left renal vein entrapment: a follow-up evaluation, Am J Kidney Dis 55:e29–e31, 2010.
Sebestyen J, Alon U. The teenager with asymptomatic proteinuria — think orthostatic first, Clin Pediatr (Phila) 50:179–182, 2011.
Gekle M. Renal tubule albumin transport, Annu Rev Physiol 267:573–594, 2005.
Gorriz JL, Martinez-Castelao A. Proteinuria: detection and role in native renal disease progression, Transplant Rev 26:3–13, 2012.
Nielsen R, Christensen EI. Proteinuria and events beyond the slit, Pediatr Nephrol 25:813–822, 2010.
Van Berkel Y, Ludwig M, van Wijk JA, Bokenkamp A. Proteinuria in Dent disease: a review of the literature, Pediatr Nephrol 32(10):1851–1859, 2017.
Bergstein JM. A practical approach to proteinuria, Pediatr Nephrol 13:697–700, 1999.
Jefferson JA, Nelson PJ, Najafian B, et?al. Podocyte disorders: core curriculum 2011, Am J Kidney Dis 58(4):666–677, 2011.
Kaplan BS, Pradhan M. Urinalysis interpretation for pediatricians, Pediatr Ann 42(3):45–51, 2013.
Mahan JD, Turman MA, Mentser M. Evaluation of hematuria, proteinuria, and hypertension in adolescents, Pediatr Clin North Am 44:1573–1589, 1997.
Quigley R. Evaluation of hematuria and proteinuria: how should a pediatrician proceed? Curr Opin Pediatr 20:140–144, 2008.
D’Agati VD, Alster JM, Jenette CJ, et?al. Association of histologic variants in FSGS clinical trial with presenting features and outcomes, Clin J Am Soc Nephrol 8(3): 399–406, 2013.
D’Agato VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis, N Engl J Med 365(25):2398–2410, 2011.
Ferris ME, Gipson DS, Kimmel PL, et?al. Trends in treatment and outcomes of survival of adolescents initiating end-stage renal disease care in the United States of America, Pediatr Nephrol 21:1020–1026, 2006.
Has C, Sparta G, Kirtsi D, et?al. Integrin ?3 mutations with kidney, lung, and skin disease, N Engl J Med 366(16):1508–1514, 2012.
Hodson EM, Craig JC. Corticosteroid therapy for steroid-sensitive nephrotic syndrome in children: dose or duration, J Am Soc Nephrol 24:7–9, 2013.
Hodson EM, Willis NS, Craig JC. Interventions for idiopathic steroid-resistant nephrotic syndrome in children, Cochrane Database Syst Rev (11):CD003594, 2010.
Hoyer PF. New lessons from randomized trials in steroid-sensitive nephrotic syndrome:clear evidence, Kidney Int 87(1):17–19, 2015.
Ishikura K, Yoshikawa N, Nakazato H, et?al. Morbidity in children with frequently relapsing nephrosis: 10-year follow-up of a randomized controlled trial, PediatrNephrol 30(3):459–468, 2015.
Jellouli M, Charfi R, Maalej B, et al. Rituximab in the management of pediatric steroid-resistant nephrotic syndrome: a systematic review, J Pediatr 197:191–197, 2018.
Kapur G, Valentini RP, Imam AA, et al. Treatment of severe edema in children with nephrotic syndrome with diuretics alone — a prospective study, Clin J Am Soc Nephrol 4:907–913, 2009.
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. (2012) KDIGO clinical practice guidelines for glomerulonephritis, Kidney Int Suppl. 2:139–274, 2012.
Kitiyakara C, Eggers P, Kopp JB. Twenty-one-year trend in ESRD due to focal segmental glomerulonephritis in the United States, Am J Kidney Dis 44:815–825, 2004.
Lombel RM, Gipson DS, Hodson EM. Treatment of steroid-sensitive nephrotic syndrome: new guideline from KDIGO, Pediatr Nephrol 28:415–426, 2013.
McCaffrey J, Lennon R, Webb NJ. The non-immunosuppressive management of childhood nephrotic syndrome, Pediatr Nephrol 31(9):1383–1402, 2016.
Mele C, Iatropoulos P, Donadellli R, et?al. MYO1E mutations and childhood familial focal segmental glomerulosclerosis, N Engl J Med 365(4):295–306, 2011.
Noone DG, Iijima K, Parekh R. Idiopathic nephrotic syndrome in children, Lancet 392:61–72, 2018.
Okamoto K, Tokunaga K, Doi K, et?al. Common variation in GPC5 is associated with acquired nephrotic syndrome, Nat Genet 43(5):459–463, 2011.
Pasini A, Benetti E, Conti G, et al. The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: Part diagnosis and treatment of the first episode and the first relapse, Ital J Pediatr 43(1):41, 2017.
Ravani P, Bonanni A, Rossi R, et?al. Anti-CD antibodies for nephrotic syndrome in children, Clin J Am Soc Nephrol 11:710–720, 2016.
van Husen M, Kemper MJ. New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome, Pediatr Nephrol 26:881–892, 2011.
Wei C, El Hindi S, Li J, et?al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis, Nat Med 17(8):952–960, 2011.
Herman ES, Klotman PE. HIV-associated nephropathy: epidemiology, pathogenesis, and treatment, SeminNephrol 23:200–208, 2003.
Lien YH, Lai LW. Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis, Nat Rev Nephrol 7:85–95, 2011.
Sitprija V. Nephropathy in falciparum malaria, Kidney Int 34:867, 1998.
Avni EF, Vandenhoute K, Devriendt A, et?al. Update on congenital nephrotic syndromes and the contribution of US, Pediatr Radiol 41:76–81, 2011.
Benoit G, Machuca E, Antignac C. Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations, Pediatr Nephrol 25(9):1621–1632, 2010.
Boscher AK, Weber S. Educational paper: the podocytopathies, Eur J Pediatr 171:1151–1160, 2012.
Galloway WH, Mowat AP. Congenital microcephaly with hiatus hernia and nephrotic syndrome in two sibs, J Med Genet 5:319, 1968.
Jalanko H. Congenital nephrotic syndrome, Pediatr Nephrol 24:2121–2128, 2009.
Jefferson JA, Nelson PJ, Najafian B, et?al. Podocyte disorders: core curriculum 2011, Am J Kidney Dis 58:666–677, 2011.
Lau KK, Chan HH, Massicotte P, Chan AK. Thrombotic complications of neonates and children with congenital nephrotic syndrome, Curr Pediatr Rev 10(3):169–176, 2014.
Greenbaum LA, Benndorf R, Smoyer WE. Childhood nephrotic syndrome — current and future therapies, Nat Rev Nephrol 8:445–458, 2012.
Kamei K, Ishikura K, Sako M, et?al. Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo controlled trial of rituximab, Pediatr Nephrol 32(11):2071–2078, 2017.
Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease, Clin J Am Soc Nephrol 7:513–520, 2012.
Siddall EC, Radhakrishnan J. The pathophysiology of edema formation in the nephrotic syndrome, Kidney Int 82:635–642, 2012.
Trautmann A, Bodria M, Ozaltin F, et?al. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the Podonet registry cohort, Clin J Am Soc Nephrol 10(4):592–600, 2015.
Wu HM, Tang JL, Cao L, et?al. Interventions for preventing infection in nephrotic syndrome, Cochrane Database Syst Rev (4):CD003964, 2012.
Baum M: Renal tubular development. In Avner ED, Harmon WE, Niaudet P, et al, editors: Pediatric nephrology, ed 6, Heidelberg, Germany, 2009, Springer-Verlag, pp 65–94.
Cho HY, Lee BH, Choi HJ, et?al. Renal manifestations of Dent disease and Lowe syndrome, Pediatr Nephrol 23:243–249, 2008.
Emma F, Pizzini C, Tessa A, et?al. «Bartter-like» phenotype in Kearns-Sayre syndrome, Pediatr Nephrol 21:355–360, 2006.
Fremont OT, Chan JC. Understanding Bartter syndrome and Gitelman syndrome, World J Pediatr8:25–30, 2012.
Garnier A, Dreux S, Vargas-Poussou R, et?al. Bartter syndrome prenatal diagnosis based on amniotic fluid biochemical analysis, Pediatr Res 67(3):300–303, 2010.
Laghmanni K, Beck BB, Yang SS, et?al. Polyhydramnios, transient antenatal Bartter’s syndrome, and MAGED2 mutations, N Engl J Med 374(19):1853–1863, 2016.
Li F, Yue Z, Xu T, et al. Dent disease in Chinese children and findings from heterozygousmothers: phenotypic heterogeneity, fetal growth, and 10 novel mutations, J Pediatr 174:204–210, 2016.
Matsunoshita N, Nozu K, Shono A, et?al. Differential diagnosis of Bartter syndrome, Gitelman syndrome, and pseudo-Bartter/Gitelman syndrome based on clinical characteristics, Genet Med 18(2):180–188, 2016.
Plumb LA, van’t Hoff W, Kleta R, et?al. Renal apnoea: extreme disturbance of homeostasis in a child with Bartter syndrome type IV, Lancet 388:631–632, 2016.
Seyberth HW. An improved terminology and classification of Bartter-like syndromes, Nat Clin Pract Nephrol 4:560–570, 2008.
Seyberth HW, Schlingmann KP. Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects, Pediatr Nephrol 26:1789–1802, 2011.
Seyberth HW, Weber S, Komhoff M. Bartter’s and Gitelman’s syndrome, Curr Opin Pediatr 29:179–186, 2017.
Shima Y, Nozu K, Nozu Y, et?al. Recurrent EIARF and PRES with severe renal hypouri-cemia by compound heterozygous SLC2A9 mutation, Pediatrics 127(6):e1621-e1625, 2011.
Sung CC, Chen YS, Lin SH. Family paralysis, Lancet 377:352, 2011.
Ciccia E, Devarajan P: Pediatric acute kidney injury: prevalence, impact and management challenges, Int J Nephrol Renovasc Dis 10:77–84, 2017.
Devarajan P: Acute kidney injury: still misunderstood and misdiagnosed, Nat RevNephrol 13(3):137–138, 2017.
Kaddourah A, Basu RK, Bagshaw SM, et al: Epidemiology of acute kidney injury in critically ill children and young adults, N Engl J Med 376(1):11–20, 2017.
Kellum JA, Chawla LS, Keener C, et al: The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock, Am J Respir Crit Care Med 193(3):281–287, 2016.
McCaffrey J, Dhakal AK, Milford DV, et al: Recent developments in the detection and management of acute kidney injury, Arch Dis Child 102(1):91–96, 2017.
Vanmassenhove J, Kielstein J, J?rres A, Van Biesen W: Intensive care medicine and renal transplantation 1—management of patients at risk of acute kidney injury, Lancet 389:2139–2148, 2017.
Zarbock A, Kellum JA, Schmidt C, et al: Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury, JAMA 315(20):2190–2199, 2016.
ESCAPE Trial Group: Strict blood pressure control and progression of renal failure in children, N Engl J Med 361:1639–1650, 2009.
Harambat J, van Stralen KJ, Kim JJ, et?al: Epidemiology of chronic kidney disease in children, Pediatr Nephrol 27:363–373, 2012.
KDIGO clinical practice guideline for anemia in chronic kidney disease, Kidney IntSuppl 2:280–335, 2012.
KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease: blood pressure management in children with CKD ND, KidneyInt Suppl 2:372–376, 2012.
Mitsnefes MM, Laskin BL, Dahhou M, et?al: Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1990-2010, JAMA 309(18):1921–1928, 2013.
Mitsnefes MM: Cardiovascular disease in children with chronic kidney disease, J AmSoc Nephrol 23:578–585, 2012.
National Kidney Foundation: KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target, Am J Kidney Dis 50(3):471–530, 2007.
National Kidney Foundation: KDOQI clinical practice guideline for nutrition in children with CKD: 2008 update, Am J Kidney Dis 53(3 Suppl 2):S1–S124, 2009.
National Kidney Foundation, KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification: Am J Kidney Dis 39(2 Suppl 1):s1–s266, 2002.
Packham DK, Rasmussen HS, Lavin PT, et?al: Sodium zirconium cyclosilicate in hyperkalemia, N Engl J Med 372(3):222–232, 2015.
Schaefer B, Wuhl E: Progression in chronic kidney disease and prevention strategies, Eur J Pediatr 1717(11):1579–1588, 2012.
The Medical Letter: Ferric citrate (auryxia) for hyperphosphatemia, Med Lett DrugsTher 57(1483):166–167, 2015.
Warady BA, Abraham AG, Schwartz GJ, et?al: Predictors of rapid progression of glomerular and non-glomerular kidney disease in children: the CKiD cohort, AmJ Kidney Dis 65:878–888, 2015.
Weir MR, Bakris GL, Bushinsky DA, et?al: Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors, N Engl J Med 372(3):21–220, 2015.
Wesseling-Perry K, Salusky IB: Chronic kidney disease: mineral and bone disorder in children, Semin Nephrol 33:169–179, 2013.
Wong CJ, Moxey-Mims M, Jerry-Fluker J, et al: CKiD (CKD in children) prospective cohort study: a review of current findings, Am J Kidney Dis 60:1002–1011, 2012.
Wong CS, et?al: Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study, ClinJ Am Soc Nephrol 4:812–819, 2009.
Muller D, Goldstein SL: Hemodialysis in children with end-stage renal disease, NatRev Nephrol 7:650–658, 2011.
North American Pediatric Renal Transplant Cooperative Study (NAPRTCS): 2011 Annual report. Rockville, MD.
Schaefer F, Warady BA: Peritoneal dialysis in children with end-stage renal disease, Nat Rev Nephrol 7:659–668, 2011.
Warady BA, Neu AM, Schaefer F: Optimal care of the infant, child, and adolescent on dialysis: 2014 update, Am J Kidney Dis 64:128–142, 2014.
2016 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2016.
Chaudhuri A, Ozawa M, Everly MJ, et?al: The clinical impact of humoral immunity in pediatric renal transplantation, J Am Soc Nephrol 24(4):655–664, 2013.
Danziger-Isakov L, Kumar D, AST infectious diseases community of practice: Vac-cination in solid organ transplantation, Am J Transplant 13(Suppl 4):311–317, 2013.
Haller MC, Royuela A, Nagler EV, et?al: Steroid avoidance or withdrawal for kidney transplant recipients, Cochrane Database Syst Rev (8):CD005632, 2016.
Laskin BL, Mitsnefes MM, Dahhou M, et?al: The mortality risk with graft function has decreased among children receiving a first kidney transplant in the United States, Kidney Int 87(3):575–583, 2015.
Mynarek M, Hussein K, Kreipe HH, Maecker-Kolhoff B: Malignancies after pediatrickidney transplantation: more than PTLD?, Pediatr Nephrol 29(9):1517–1528, 2014.
Nehus E, Liu C, Hooper DK, et?al: Clinical practice of steroid avoidance in pediatric kidney transplantation, Am J Transplant 15(8):2203–2210, 2015.
North American Pediatric Renal Trials and Collaborative Studies: Annual Transplant Report, 2014.
Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2015 Annual Data Report. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, 2016. https://srtr.transplant.hrsa.gov.
Organ Procurement and Transplantation Network.U.S. Department of Health and Human Services. Update 9/12/2017.
Rees L, Schaefer F, Schmitt CP, et al: Chronic dialysis in children and adolescents: problems and outcomes, Lancet Child Adolesc Health 1: 68–77, 2017.
Sadaka B, Alloway RR, Woodle ES: Management of antibody-mediated rejection in transplantation, Surg Clin North Am 93(6):1451–1466, 2013.
Van Arendonk KJ, Boyarsky BJ, Orandi BJ, et?al: National trends over 25 years in pediatric kidney transplant outcomes, Pediatrics 133(4):594–601, 2014.
Varnell CD, Fukuda T, Kirby CL, et?al: Mycophenolate mofetil-related leukopenia in children and young adults following kidney transplantation: influence of genes and drugs, Pediatr Transplant 21(7):2017.
Vincenti F, Rostaing L, Grinyo J, et?al: Belatacept and long-term outcomes in kidney transplantation, N Engl J Med 374(4):333–343, 2016. Erratum in N Engl J Med 374(7):698, 2016.
Yanik EL, Smith JM, Shiels MS, et?al: Cancer risk after pediatric solid organ transplanta-tion, Pediatrics 139(5):2017.
Zhang H, Zheng Y, Liu L, et?al: Steroid avoidance or withdrawal regimens in paediatric kidney transplantation: a meta-analysis of randomised controlled trials, PLoS ONE 11(3):e0146523, 2016